ABCA1
2 papers study it36 more mention it5 findings
- Humans2
Upstream
1Type 2 diabetes
downin humans1
1 study
Type 2 diabetes
downin humans1
Type 2 diabetes decreases ABCA1 in humans.
“Circulatory ABCA1 and ABCG1 levels were significantly lower in T2DM+A and T2DM than in NGT group”
Humansin T2DM and T2DM with atherosclerosis
ADA Scientific Sessions 2026 abstract
Associations
4Atherosclerosis
upin humans1
1 study
Atherosclerosis
upin humans1
ABCA1 predicts atherosclerosis in humans (AUC 0.782, 95% CI 0.684-0.861).
“ROC curve analysis for ABCA1 yielded an AUC of 0.782 (95% CI: 0.684-0.861; Cutoff 0.5086 ng/mL)”
Humansdiscriminating atherosclerosis risk/groups
ADA Scientific Sessions 2026 abstract
Cholesterol efflux
upin humans1
1 study
Cholesterol efflux
upin humans1
ABCA1 is associated with cholesterol efflux in humans.
“HDL functionality as measured by CE was significantly reduced in patients with T2DM+A and T2DM, and positively associated with ABC transporters.”
Humansin T2DM and NGT subjects
ADA Scientific Sessions 2026 abstract
P-TAU181
upin humans1
1 study
P-TAU181
upin humans1
ABCA1 is associated with P-TAU181 in humans.
“Both proteins positively correlated with phospho-Tau (181), a classical hallmark of DAT.”
Humansplasma
Aging and disease
Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
Cardiovascular disease is associated with ABCA1 in humans.
“Finally, the differential expression of ABCA1 and APOH proteins was verified, in an independent cohort also including controls and patients with CVD alone.”
Humansin an independent cohort including controls, DAT, and CVD patientsplasma
Aging and disease
Funding
4 grants since 2020National Institute on AgingUS$3mBrightFocus FoundationUS$200kNatural Science Foundation of Hunan Province
Natural Science Foundation of Hunan ProvinceCentral South University2026
BrightFocus FoundationWashington University in St. LouisUS$200k2022–2024
Nonlipogenic ABCA1 inducers for ADRD
National Institute on AgingUniversity of ArizonaUS$756.9k2022–2027
ApoE, ABCA1 and endosomal dysregulation in AD
National Institute on AgingUniversity of Southern CaliforniaUS$717.3k2020–2025